Xiaoqin Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaoqin Tang has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Abbey Thompson
Johnson & Johnson, Johnson & Johnson Innovative Medicine 1125 Trenton Harbourton Road, Titusville, NJ 08560, USA
1 shared publication - Alan Fossa
University of Michigan School of Public Health, Department of Epidemiology, Ann Arbor, MI, United States
1 shared publication - Bin Liu
Xianyang Key Laboratory of Molecular Imaging and Drug Synthesis, School of Pharmacy, Shaanxi University of International Trade & Commerce , Xianyang , Shaanxi , China
1 shared publication - Carly J. Paoli
Johnson & Johnson, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA
1 shared publication - Chang Zhang
Johnson & Johnson, Johnson & Johnson Innovative Medicine 1125 Trenton Harbourton Road, Titusville, NJ 08560, USA
1 shared publication - Deeksha Doddahonnaiah
Nference Cambridge Massachusetts USA
1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by Wiley in Pulmonary Circulation
- Vol. 16 (2) , e70294
Use of Machine‐Learning Models to Identify Clinical Features Associated With A Future Clinical Worsening Event in Patients With Pulmonary Arterial Hypertension
Clinical worsening events are increasingly recognized as a meaningful outcome in pulmonary arterial hypertension (PAH). We applied machine‐learning models to real‐world data to identify clinical features that may predict clinical worsening events in PAH. Data were obtained retrospectively from the electronic health records of adults diagnosed with PAH at Mayo Clinic locations (January 2015–December 2019). Machine‐learning LASSO regularized logistic regression models were developed to analyze the association between 100 clinical features and occurrence of clinical worsening events. In total, 455 patients were included (mean age 62.1 years; 59.3% female). Of these, 232 (51.0%) experienced a clinical worsening event after a median (quartile 1, quartile 3) of 10.9 (4.1, 21.4) months. The best‐performing model had an area under the curve of 0.78, sensitivity of 78%, and specificity of 59%. The model identified 11 clinical features associated with clinical worsening events in PAH with a non‐zero coefficient: baseline age, body mass index (BMI), creatinine level, red cell (erythrocyte) distribution width (RDW), mean pulmonary arterial pressure, pulmonary vascular resistance, sodium concentration, and QT interval, along with dyspnea, number of clinic visits, and other forms of heart disease within a 1‐month window before a clinical worsening event. Baseline RDW and BMI, and number of clinic visits within the 1‐month window were statistically significantly associated with clinical worsening events. Our study used machine‐learning models to identify clinical features associated with risk of clinical worsening events in PAH. Automation of risk prediction could lead to earlier therapeutic intervention to optimize patient outcomes.
- 1 April 2026
- Published by Wiley in Pulmonary Circulation
- Vol. 16 (2) , e70294
Open AccessUse of Machine‐Learning Models to Identify Clinical Features Associated With A Future Clinical Worsening Event in Patients With Pulmonary Arterial Hypertension
Clinical worsening events are increasingly recognized as a meaningful outcome in pulmonary arterial hypertension (PAH). We applied machine‐learning models to real‐world data to identify clinical features that may predict clinical worsening events in PAH. Data were obtained retrospectively from the electronic health records of adults diagnosed with PAH at Mayo Clinic locations (January 2015–December 2019). Machine‐learning LASSO regularized logistic regression models were developed to analyze the association between 100 clinical features and occurrence of clinical worsening events. In total, 455 patients were included (mean age 62.1 years; 59.3% female). Of these, 232 (51.0%) experienced a clinical worsening event after a median (quartile 1, quartile 3) of 10.9 (4.1, 21.4) months. The best‐performing model had an area under the curve of 0.78, sensitivity of 78%, and specificity of 59%. The model identified 11 clinical features associated with clinical worsening events in PAH with a non‐zero coefficient: baseline age, body mass index (BMI), creatinine level, red cell (erythrocyte) distribution width (RDW), mean pulmonary arterial pressure, pulmonary vascular resistance, sodium concentration, and QT interval, along with dyspnea, number of clinic visits, and other forms of heart disease within a 1‐month window before a clinical worsening event. Baseline RDW and BMI, and number of clinic visits within the 1‐month window were statistically significantly associated with clinical worsening events. Our study used machine‐learning models to identify clinical features associated with risk of clinical worsening events in PAH. Automation of risk prediction could lead to earlier therapeutic intervention to optimize patient outcomes.
- Open Access
- 22 April 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 243, 108112
A real-world comparative effectiveness analysis of macitentan versus ambrisentan and bosentan on hospitalizations and healthcare resource utilization in patients with pulmonary arterial hypertension
- 22 April 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 243, 108112
Open AccessA real-world comparative effectiveness analysis of macitentan versus ambrisentan and bosentan on hospitalizations and healthcare resource utilization in patients with pulmonary arterial hypertension
- Open Access
- 31 August 2024
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (12) , 1998-2007
Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study
- 31 August 2024
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (12) , 1998-2007
Open AccessChanges in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study
- 16 May 2024
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 240, 113973
Biomimetic platelet-like nanoparticles enhance targeted hepatocellular carcinoma therapy
- 16 May 2024
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 240, 113973
Biomimetic platelet-like nanoparticles enhance targeted hepatocellular carcinoma therapy
- Open Access
- 17 May 2022
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 237 (4) , 623-625
Crystal structure of 1-isopropyl-3-(prop-1-en-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, C11H15N5
C11H15N5, monoclinic, P21/c (no. 14), a = 9.5677(16) Å, b = 8.1755(15) Å, c = 14.846(3) Å, β = 93.783(4)°, V = 1158.7(4) Å3, Z = 4, R gt (F) = 0.0473, wR ref (F 2) = 0.1425, T = 173 K.
- 17 May 2022
- Published by Walter de Gruyter GmbH in Zeitschrift für Kristallographie - New Crystal Structures
- Vol. 237 (4) , 623-625
Open AccessCrystal structure of 1-isopropyl-3-(prop-1-en-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, C11H15N5
C11H15N5, monoclinic, P21/c (no. 14), a = 9.5677(16) Å, b = 8.1755(15) Å, c = 14.846(3) Å, β = 93.783(4)°, V = 1158.7(4) Å3, Z = 4, R gt (F) = 0.0473, wR ref (F 2) = 0.1425, T = 173 K.
- Open Access
- 8 October 2015
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 17 (10) , e226
Sharing Physician Notes Through an Electronic Portal is Associated With Improved Medication Adherence: Quasi-Experimental Study
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet
- 8 October 2015
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 17 (10) , e226
Open AccessSharing Physician Notes Through an Electronic Portal is Associated With Improved Medication Adherence: Quasi-Experimental Study
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet